(Q45412274)

14 December 2017

title

Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis (English)

1 reference

14 December 2017

0 references

1 reference

hepatocellular carcinoma

1 reference

Oscar Arrieta

1

1 reference

14 December 2017

Jose Luis Rodriguez-Diaz

2

1 reference

14 December 2017

Vanessa Rosas-Camargo

3

1 reference

14 December 2017

Daniela Morales-Espinosa

4

1 reference

14 December 2017

Sergio Ponce de Leon

5

1 reference

14 December 2017

David Kershenobich

6

1 reference

14 December 2017

Eucario Leon-Rodriguez

7

1 reference

14 December 2017

language of work or name

English

0 references

publication date

1 October 2006

1 reference

14 December 2017

1 reference

14 December 2017

volume

107

1 reference

14 December 2017

issue

8

1 reference

14 December 2017

page(s)

1852-1858

1 reference

A long-term follow-up study on risk factors for hepatocellular carcinoma among Japanese patients with liver cirrhosis

14 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

Colchicine sensitizes human hepatocellular carcinoma cells to damages caused by radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

https://api.crossref.org/works/10.1002%2FCNCR.22198

1 reference

7 January 2021

Trends in survival of patients with hepatocellular carcinoma between 1977 and 1996 in the United States.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Hepatitis C-associated hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Hepatocellular carcinoma: the high-risk patient

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

The epidemiology and prevention of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Colchicine: 1998 update.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Microtubules as a target for anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Effect of colchicine on lymphocyte and monocyte function and its relation to fibroblast proliferation in primary biliary cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Microtubules in transcellular movement of procollagen.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Effects of colchicine on collagenase in cultures of rheumatoid synovium

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Effect of colchiceine and ursodeoxycholic acid on hepatocyte and erythrocyte membranes and liver histology in experimentally induced carbon tetrachloride cirrhosis in rats

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Colchicine for alcoholic and non-alcoholic liver fibrosis or cirrhosis.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Colchicine treatment of alcoholic cirrhosis: a randomized, placebo-controlled clinical trial of patient survival

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Colchicine in the treatment of cirrhosis of the liver.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Prospective analysis of risk factors for hepatocellular carcinoma in patients with liver cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Hepatitis C virus related cirrhosis: time to occurrence of hepatocellular carcinoma and death.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Risk factors for hepatocellular carcinoma in Hepatitis C patients with sustained virologic response to interferon therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

HBV induced carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Hepatitis C virus and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Hepatocellular carcinoma in Italian patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Prevention of hepatocellular carcinoma development associated with chronic hepatitis by anti-fas ligand antibody therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22198

7 January 2021

Identifiers

DOI

10.1002/CNCR.22198

1 reference

14 December 2017

1 reference